Reply to Zhipeng Mai, Weigang Yan, and Zhien Zhou’s Letter to the Editor re: Gabriela Ilie, Ricardo Rendon, Ross Mason, et al. A Comprehensive 6-mo Prostate Cancer Patient Empowerment Program Decreases Psychological Distress Among Men Undergoing Curative Prostate Cancer Treatment: A Randomized Clinical Trial. Eur Urol 2023;83:561–70 von Ilie, Gabriela, Rutledge, Robert D.H.

Volltext

Reply to Tianrui Feng, Miao Ren, and Zhien Zhou’s Letter to the Editor re: Peter Fletcher, Marta De Santis, Simona Ippoliti, et al. Vector Prostate Biopsy: A Novel Magnetic Resonance Imaging/Ultrasound Image Fusion Transperineal Biopsy Technique Using Electromagnetic Needle Tracking Under Local Anaesthesia. Eur Urol 2023;83:249–56 von Fletcher, Peter, Kastner, Christof

Volltext

Reply to Weigang Yan, Zhien Zhou, Hanzhong Li's Letter to the Editor re: Jeffrey J. Tosoian, Debasish Sundi, Bruce J. Trock, et al. Pathologic Outcomes in Favorable-risk Prostate Cancer: Comparative Analysis of Men Electing Active Surveillance and Immediate Surgery. Eur Urol 2016;69:576–81 von Tosoian, Jeffery J, Trock, Bruce J, Ballentine Carter, H, Mamawala, Mufaddal

Volltext

Artificial intelligence-based model for lymph node metastases detection in bladder cancer von Mai, Zhipeng, Zhou, Yi, Zhou, Zhien, Yan, Weigang

Volltext

Long non‐coding RNA ADAMTS9‐AS1 inhibits the progression of prostate cancer by modulating the miR‐142‐5p/CCND1 axis von Zhou, Zhien, Wu, Xingcheng, Zhou, Yi, Yan, Weigang

Volltext

The transverse and vertical distribution of prostate cancer in biopsy and radical prostatectomy specimens von Mai, Zhipeng, Zhou, Zhien, Yan, Weigang, Xiao, Yu, Zhou, Yi, Liang, Zhiyong, Ji, Zhigang, Li, Hanzhong

Volltext

Tetramethylpyrazine reduces prostate cancer malignancy through inactivation of the DPP10‑AS1/CBP/FOXM1 signaling pathway von Zhou, Yi, Zhou, Zhien, Ji, Zhigang, Yan, Weigang, Li, Hanzhong, Yu, Xiao

Volltext

Tumor characteristics, treatments, and survival outcomes in prostate cancer patients with a PSA level < 4 ng/ml: a population-based study von Zheng, Zhibo, Zhou, Zhien, Yan, Weigang, Zhou, Yi, Chen, Chuyan, Li, Hanzhong, Ji, Zhigang

Volltext

Comparison of the efficacy and safety profiles of generic and branded leuprorelin acetate microspheres in patients with prostate cancer von Zhou, Zhien, Zhou, Yi, Yan, Weigang, Feng, Tianrui, Liang, Zhen

Volltext

Association between body mass index and sex hormones among men: Evidence from cross-sectional and Mendelian randomization studies von Chen, Junhao, Wang, Zilin, Zhou, Yi, Zhou, Zhien, Yan, Weigang

Volltext

Unilateral lesion detected on preoperative multiparametric magnetic resonance imaging and MRI/US fusion-guided prostate biopsy is not an appropriate indication for focal therapy in... von Zhou, Zhien, Zhou, Yi, Yan, Weigang, Sun, Hao, Li, Qianyue, Li, Hanzhong, Ji, Zhigang

Volltext

Re: Stephanie Guillaumier, Max Peters, Manit Arya, et al. A Multicentre Study of 5-year Outcomes Following Focal Therapy in Treating Clinically Significant Nonmetastatic Prostate C... von Zhou, Zhien, Zhou, Yi, Yan, Weigang

Volltext

The biological functions and mechanism of miR-212 in prostate cancer proliferation, migration and invasion via targeting Engrailed-2 von Zhou, Yi, Ji, Zhigang, Yan, Weigang, Zhou, Zhien, Li, Hanzhong

Volltext

Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer von Yan, Weigang, Zhou, Yi, Zhou, Zhien, Ji, Zhigang, Li, Hanzhong

Volltext

Development and internal validation of a prediction model of prostate cancer on initial transperineal template-guided prostate biopsy von Chen, Yuliang, Zhou, Zhien, Zhou, Yi, Wu, Xingcheng, Xiao, Yu, Ji, Zhigang, Li, Hanzhong, Yan, Weigang

Volltext

I low-dose-rate prostate brachytherapy and radical prostatectomy in patients with prostate cancer von Zhou, Zhien, Yan, Weigang, Zhou, Yi, Zhang, Fuquan, Li, Hanzhong, Ji, Zhigang

Volltext

125I low‑dose‑rate prostate brachytherapy and radical prostatectomy in patients with prostate cancer von Zhou, Zhien, Yan, Weigang, Zhou, Yi, Zhang, Fuquan, Li, Hanzhong, Ji, Zhigang

Volltext

125 I low-dose-rate prostate brachytherapy and radical prostatectomy in patients with prostate cancer von Zhou, Zhien, Yan, Weigang, Zhou, Yi, Zhang, Fuquan, Li, Hanzhong, Ji, Zhigang

Volltext

A net-work meta-analysis of the cardiac safety for next-generation hormonal agents in treating castration-resistant prostate cancer: How to choose drugs appropriately? von Zhen, Liang, Juan, Wang, Tianrui, Feng, Yuliang, Chen, Zhien, Zhou, Yi, Zhou, Weigang, Yan, Fenghong, Cao

Volltext

The direct prognosis comparison of 125I low-dose-rate brachytherapy versus laparoscopic radical prostatectomy for patients with intermediate-risk prostate cancer von Liang, Zhen, Yuliang, Chen, Zhu, Ming, Zhou, Yi, Wu, Xingcheng, Li, Hanzhong, Fan, Bu, Zhou, Zhien, Yan, Weigang

Volltext